Interventions Can Improve Administration of VTE Prophylaxis
Improvement seen with electronic alert-triggered, patient-centered education bundle intervention or nurse feedback intervention
Diagnosis & Disease Information
Risk for First-Time Clot Events Raised After COVID-19 Diagnosis
Incidence is highest in first week, but remains elevated up to 49 weeks after COVID-19 diagnosis
Apixaban Noninferior to Enoxaparin for Postoperative VTE Prophylaxis
Fewer compliance events seen with apixaban versus enoxaparin for extended-duration VTE prophylaxis after abdominopelvic oncologic surgery
VTE Risk Higher With Arteriovenous Grafts vs Fistulas
The increased risk for venous thromboembolism with an arteriovenous graft is one factor for clinicians and patients to consider in the choice of vascular access for hemodialysis.
Risk for VTE Up During 5 Years After Prostate Cancer Diagnosis
Incidence proportion ratios decreased from 2.53 at 6 months to 1.59 at 5 years of follow-up
Priapism Identified as a Risk Factor for Embolism
Men with a history of priapism had increased risk for pulmonary embolism compared with men with other forms of sexual dysfunction.
Apixaban Tied to Lower Risk for Recurrent VTE in Dialysis Population
Apixaban is a direct oral anticoagulant that relies less on kidney excretion.
Cardiovascular Mortality Decreasing in the Dialysis Population
Although cardiovascular mortality rates declined, clinicians should still be vigilant to prevent poor outcomes in patients receiving dialysis, according to investigators.
COVID-19 Linked to Increased Risk for DVT, PE, Bleeding
Rate ratios were highest for critical COVID-19, and during first versus second and third pandemic waves in Sweden
Scientists Report ‘Rogue Antibodies’ Behind Severe Clotting With COVID-19
Study authors suggest future research assess the potential benefits of screening COVID-19 patients for antiphospholipids and other autoantibodies
- Loading...
Loading...
Next post in Lupus Nephritis
Loading... 
Loading...